Table 4.
ORs and 95% CIs of muscle mass and muscle strength for NAFLD
Men | ||||
Variable | Model 1 | Model 2 | ||
OR (95%CI) | P | OR (95%CI) | P | |
Muscle mass, per SD decrease | 2.91 (1.58, 5.35) | 0.001 | 2.88 (1.52, 5.46) | 0.001 |
Muscle strength, per SD decrease | 1.15 (1.04, 1.26) | 0.004 | 1.15 (1.02, 1.28) | 0.021 |
Women | ||||
Variable | Model 1 | Model 2 | ||
OR (95%CI) | P | OR (95%CI) | P | |
Muscle mass, per SD decrease | 1.89 (1.51, 2.38) | <0.001 | 2.08 (1.63, 2.67) | <0.001 |
Muscle strength, per SD decrease | 1.05 (0.99, 1.11) | 0.058 | 1.01 (0.95, 1.07) | 0.716 |
Results are given as OR (95% CI) for NAFLD as outcome stratified by gender. Results in bold reflect significant findings with a P value < 0.05. Model 1: adjusted for age and weight. Model 2: adjusted for age, weight, BMI, TG, ALT. NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; TG, triglyceride; ALT, alanine aminotransferase